Financhill
Back

Summit Therapeutics, Inc. 10K Form

Sell
46

SMMT
Summit Therapeutics, Inc.

Last Price:
$18.31
Seasonality Move:
26.83%

7 Day Trial

ALL ACCESS PASS

$ 7

Receive SMMT News And Ratings

See the #1 stock for the next 7 days that we like better than SMMT

SMMT Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-95.1M
Price / Cash Flow: 0
Annual Sales: $0.26
Price / Book: 70.9

Profitability

EPS (TTM): -1.24180
Net Income (TTM): $-921.6M
Gross Margin: $-89K
Return on Equity: -283.98%
Return on Assets: -241.51%

Summit Therapeutics, Inc. Earnings Forecast

Key Summit Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 22 years have been positive in 10 years.

Summit Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SMMT
CUSIP: 86627R
Website: smmttx.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 3.8
Quick Ratio: 3.68

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SMMT Technical Analysis vs Fundamental Analysis

Sell
46
Summit Therapeutics, Inc. (SMMT) is a Sell

Is Summit Therapeutics, Inc. a Buy or a Sell?